Français
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
metrorrhagia/carbohydrate
Le lien est enregistré dans le presse-papiers
14 résultats
Ovarian and endometrial function during hormonal contraception.
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
This report addresses the balance of benefits and risks from changes in ovarian and endometrial function from hormonal contraception. The main mode of action of hormonal contraception is inhibition of ovulation, due chiefly to the dose of oestrogen in combined oral contraceptives. With 20 microg
Efficacy and safety of a monophasic and a triphasic oral contraceptive containing norgestimate.
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
Both monophasic and triphasic formulations of ethinyl estradiol plus norgestimate, a progestin with marked progesterone-receptor affinity and minimal androgen-receptor affinity, have been evaluated in numerous clinical studies designed to determine if norgestimate's receptor-binding profile provides
OC practice guidelines: minimizing side effects.
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
The side effects of oral contraceptives (OCs) can be minimized by appropriate OC selection. Side effects or perceived side effects that manifest themselves physically--e.g., weight gain, breakthrough bleeding (BTB), nausea, headache, breast tenderness, mood swings, acne, and hirsutism--are the most
The estrogen component of OCs: cardiovascular benefits and risks.
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
The relationship of oral contraceptive (OC) use to risk of venous thrombolism, stroke, and myocardial infarction continues to be evaluated. The estrogen component of combination OCs, which is primarily responsible for maintaining the endometrium and minimizing breakthrough bleeding (BTB) and
Norgestimate: a clinical overview of a new progestin.
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
The efficacy and safety of a new monophasic oral contraceptive, norgestimate/ethinyl estradiol, containing the third-generation progestin, norgestimate (250 micrograms), and ethinyl estradiol (35 micrograms), are reviewed. Norgestimate/ethinyl estradiol demonstrates excellent contraceptive efficacy,
[Use of orlistat (xenical) in the treatment of women with obesity and disorders of menstrual cycle].
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
Obesity poses a serious threat for health, being a risk factor for development of heart diseases, diabetes type II, tumors, and reproductive function failure. The aim of this study is to investigate the effect of orlistat (xenical) on the character of menstrual cycle and some metabolic indicators in
Clinical and metabolic effects of gestodene and levonorgestrel.
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
The new low-dose combination oral contraceptive (OC) containing 75 micrograms of the new progestogen gestodene (GTD) plus 30 micrograms ethinyl estradiol (EE) was clinically tested and compared with a levonorgestrel (LNG) combined pill (150 micrograms LNG plus 30 micrograms EE). In a randomized
The new era in oral contraception: pills containing gestodene, norgestimate, and desogestrel.
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
The latest advance in the 30-year evolution of oral contraceptives (OCs) is the development of three new progestogens: desogestrel, norgestimate, and gestodene. These three new agents are derivatives of levonorgestrel, a gonane hormone, and have been used to develop pills that provide effective
Supportive European data on a new oral contraceptive containing norgestimate.
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
Several European studies have been conducted to confirm the efficacy, tolerability, and safety of a new oral contraceptive (OC) combining 250 micrograms norgestimate with 35 micrograms ethinyl estradiol (Ortho-Cyclen or Cilest). In a 12-month multicenter German study of 147 women, treatment with
[Clinical study on the contraceptive effectiveness of trisiston from the Jenapharm firm].
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
Now triphasic contraceptive preparations are used widely. Some news low dose formulations are available on the market, among them Trisiston. The study was conducted to confirm clinically acceptance and effectiveness of Trisiston. There were 437 volunteers mostly multiparous, with a mean age of +/-
Progestogens: a look at the "other" hormone.
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
Health care providers need a general understanding of progestogens to use them safely and effectively in practice. These hormone formulations are used extensively in combination oral contraceptives and in hormonal replacement therapy with estrogen or alone. Although considered relatively safe for
Mechanism of action of IUDs: an ultrastructural view.
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
Endometrial samples from 64 women using different types of IUDs were used to study the ultrastructural changes of the human endometrium as influenced by nonmedicated and copper devices, using SEM and TEM in an attempt to explain the physiological mechanism of their actions. The absence of
Ethnomedicobotanical study of indigenous knowledge on medicinal plants used for the treatment of reproductive problems in Nalbari district, Assam, India.
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
BACKGROUND
Reproductive problems are becoming the most predominant health care problems in many countries. World Health Organization (WHO), in 2012, also exemplified maternal illnesses, for instance, birth asphyxia and post birth difficulties are rising at an alarming rate. In addition, not all
Hormonal contraception--what kind, when, and for whom?
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
BACKGROUND
In Germany today, one-third of the 20 million women of child-bearing age use combined oral contraceptives (COCs). In this article, we summarize the current knowledge of the mode of action, wanted and unwanted side effects, and long-term risks of COCs. The levonorgestrel intrauterine
La base de données d'herbes médicinales la plus complète soutenue par la science
- Fonctionne en 55 langues
- Cures à base de plantes soutenues par la science
- Reconnaissance des herbes par image
- Carte GPS interactive - étiquetez les herbes sur place (à venir)
- Lisez les publications scientifiques liées à votre recherche
- Rechercher les herbes médicinales par leurs effets
- Organisez vos intérêts et restez à jour avec les nouvelles recherches, essais cliniques et brevets
Tapez un symptôme ou une maladie et lisez des informations sur les herbes qui pourraient aider, tapez une herbe et voyez les maladies et symptômes contre lesquels elle est utilisée.
* Toutes les informations sont basées sur des recherches scientifiques publiées
